AbbVie braces for ‘greater erosion’ of Humira franchise in second half of this year

AbbVie execs touted a wave of Rinvoq programs at Cowen’s annual conference on healthcare Tuesday as they brace for a tougher Humira battle in the second half of this year.

Since its first approval in rheumatoid arthritis in 2002, Humira became one of industry’s top sellers ever, adding a…